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Hyperhomocysteinemia induced by
excessive methionine intake promotes
rupture of cerebral aneurysms in
ovariectomized rats
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Yasuhisa Kanematsu1, Junichiro Satomi1, Tomoki Hashimoto2 and Shinji Nagahiro1
Abstract
Background: Hyperhomocysteinemia (HHcy) is associated with inflammation and a rise in the expression of matrix
metalloproteinase-9 (MMP-9) in the vascular wall. However, the role of HHcy in the growth and rupture of cerebral
aneurysms remains unclear.
Methods: Thirteen-week-old female Sprague-Dawley rats were subject to bilateral ovariectomy and ligation of the
right common carotid artery and fed an 8 % high-salt diet to induce cerebral aneurysms. Two weeks later, they
underwent ligation of the bilateral posterior renal arteries. They were divided into two groups and methionine
(MET) was or was not added to their drinking water. In another set of experiments, the role of folic acid (FA) against
cerebral aneurysms was assessed.
Results: During a 12-week observation period, subarachnoid hemorrhage due to aneurysm rupture was observed
at the anterior communicating artery (AcomA) or the posterior half of the circle of Willis. HHcy induced by excessive
MET intake significantly increased the incidence of ruptured aneurysms at 6–8 weeks. At the AcomA of rats treated
with MET, we observed the promotion of aneurysmal growth and infiltration by M1 macrophages. Furthermore, the
mRNA level of MMP-9, the ratio of MMP-9 to the tissue inhibitor of metalloproteinase-2, and the level of interleukin-6
were higher in these rats. Treatment with FA abolished the effect of MET, suggesting that the inflammatory response
and vascular degradation at the AcomA is attributable to HHcy due to excessive MET intake.
Conclusions: We first demonstrate that in hypertensive ovariectomized rats, HHcy induced by excessive MET intake
may be associated with the propensity of the aneurysm wall to rupture.
Keywords: Hyperhomocysteinemia, Methionine, Cerebral aneurysm rupture, Anterior communicating artery,
Macrophage, Matrix metalloproteinase-9, Tissue inhibitor of metalloproteinase-2, Folic acid
Background
Subarachnoid hemorrhage (SAH) due to the rupture of
cerebral aneurysms is a catastrophic event; its mortality
rate is high despite advances in surgical techniques and
perioperative management. Surgical clipping or endovas-
cular coiling can be performed to prevent aneurysmal
rupture. However, the mortality and morbidity rate after
the clipping or coiling of unruptured aneurysms is not
negligible [1]. A better understanding of the pathogen-
esis underlying the growth and rupture of cerebral aneu-
rysms is needed to establish new therapeutic strategies.
Homocysteine (Hcy) is a non-protein-forming, sulphur-
containing, non-essential amino acid that functions as a
key intermediate in the methionine (MET) metabolism
[2]. Hcy connects the MET- with the folate cycle. Several
B vitamins play a role in the Hcy metabolism and an
imbalance in the formation and removal of Hcy elicits
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changes in the plasma Hcy level. Some clinical studies
suggested hyperhomocysteinemia (HHcy) as a strong in-
dependent factor in coronary disease, stroke, and abdom-
inal aortic aneurysms [3–5]. Halazun et al. [6] reported
that inflammation and matrix metalloproteinase (MMP)-2
and MMP-9 induced by HHcy are key factors in the
growth of abdominal aortic aneurysms. Xu et al. [7] re-
ported that in rats, HHcy induced by a MET-containing
diet accelerated the formation of cerebral aneurysms, and
Semmler et al. [8] suggested that polymorphisms affecting
the Hcy metabolism were associated with the formation of
cerebral aneurysms. However, the role of HHcy in the
cerebral vascular structure and in the growth and rupture
of cerebral aneurysms remains poorly understood.
Based on epidemiologic evidence of a high incidence of
cerebral aneurysms in postmenopausal women, we estab-
lished a cerebral aneurysm model in female rats subjected
to hemodynamic stress, estrogen deficiency, and hyperten-
sion [9, 10]. We demonstrated that estrogen deficiency
was associated with endothelial damage and that hyper-
tension promoted the progression of cerebral aneurysms
[11]. Activation of the local renin-angiotensin system
(RAS), oxidative stress, inflammation, and sodium reten-
tion were associated with the formation of cerebral aneu-
rysms [12–14]. Despite the high incidence of aneurysm
formation at the anterior cerebral artery-olfactory artery
(ACA-OA) bifurcation of rats, none of these aneurysms
ruptured [9–15]. However, some aneurysms developed not
only at the anterior communicating artery (AcomA) but
also at the posterior half of the circle of Willis (PW), and
they ruptured [15]. The PW includes the posterior commu-
nicating and the posterior cerebral artery (PcomA, PCA).
In humans, the hazard ratio of rupture was significantly
higher for aneurysms at the AcomA and the PcomA than
for middle cerebral artery (MCA) aneurysms [16]. A bet-
ter understanding of the mechanisms underlying their
growth and rupture is of clinical importance. We exam-
ined the role of HHcy in the growth and rupture of cere-
bral aneurysms at the AcomA and PW.
Here, we show that HHcy induced by excessive MET
intake promoted the rupture of rat cerebral aneurysms
at the AcomA and PW and the growth of aneurysms at
the AcomA and that these events were associated with
an increase in pro-inflammatory-and vascular degrad-
ation molecules.
Methods
All procedures were performed with the rats under 2–4 %
isoflurane inhalation anesthesia.
Experimental animals
For aneurysm induction, 13-week-old female Sprague-
Dawley rats were subjected to right common carotid ar-
tery (CCA) ligation to induce hemodynamic stress at the
left ACA-OA bifurcation and the AcomA. They also
underwent bilateral ovariectomy immediately after right
CCA ligation. Starting on the next day, they were fed a
high-salt diet (8 % sodium chloride). Two weeks later,
they were subjected to ligation of the bilateral posterior
renal arteries to induce hypertension. The time point of
aneurysm induction was defined as the time of bilateral
posterior renal artery ligation.
Experiment 1: To assess the incidence of SAH and the
morphological aneurysmal wall changes, we prepared
two groups. One group (MET, n = 25) did, and the other
(control, n = 19) did not receive 4 mg/ml MET (Wako,
Osaka, Japan) in their drinking water. At 12 weeks after
aneurysm induction, we prepared vascular corrosion
casts of all asymptomatic rats. In a separate experiment,
another set of rats (MET, n = 6; control, n = 6) was used
to analyze the mRNA level by quantitative real-time
polymerase chain reaction (qRT-PCR) assay and the
results were compared with sham-operated rats (sham,
n = 6) fed with a standard diet including 0.3 % so-
dium chloride.
Experiment 2: To test whether folic acid (FA) prevents
the growth and rupture of cerebral aneurysms, another
set of 19 MET rats was fed FA (Sigma-Aldrich, Tokyo,
Japan) daily (4 mg/kg; MET + FA rats) to attenuate the
conversion from MET to Hcy. They were compared with
35 MET-only rats. The administration of FA and MET
was started at the same time. We also prepared six add-
itional rats in each group for qRT-PCR assay. The MET
and FA doses were based on findings reported in earlier
studies [7, 17, 18].
Rats that died within 4 weeks after aneurysm induc-
tion were excluded. As 2 to 8 weeks are needed for
plasma Hcy to return to the normal level in rats given a
diet containing FA [18], we began evaluating its effects
on aneurysmal rupture 4 weeks after the start of FA ad-
ministration. The observation period was 12 weeks. To
detect aneurysmal rupture, two blinded observers per-
formed daily neurological examinations and recorded
neurological signs, i.e., motor deficits, seizures, absence
of spontaneous activity, and death. The brains of all
symptomatic rats harbored cerebral aneurysms and
manifested SAH. None of the asymptomatic rats that
survived for 12 weeks suffered SAH. We defined the
incidence of ruptured aneurysms as the ratio of rats with
ruptured aneurysms to the total number of rats. Ruptured
aneurysms were observed under a stereomicroscope after
removing the SAH thrombus.
Blood pressure and plasma Hcy measurements
For blood pressure readings, once every 4 weeks, unanes-
thetized rats were placed on a 37 °C hot plate (NISSIN,
Tokyo, Japan) and covered with a black blanket. After
acclimatization, one blinded examiner recorded their
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average blood pressure based on three measurements ob-
tained with the tail-cuff method (Softron, Tokyo, Japan).
Blood was withdrawn 12 weeks after the last procedure;
plasma samples were stored at −80 °C until use. In
humans, plasma Hcy levels exceeding 15 nmol are re-
corded as HHcy [19].
Preparation of vascular corrosion casts
Vascular corrosion casts were prepared as previously de-
scribed [20]. Rats were transcardially perfused with hepa-
rinized phosphate-buffered saline (PBS) followed by the
injection of Batson’s No. 17 plastic (Polyscience Inc.,
Warrington, PA, USA). The left ACA-OA bifurcation and
the AcomA on the casts were inspected at 3 kV under a
scanning electron microscope (VE8800, Keyence, Osaka,
Japan). Morphological changes at the AcomA were evalu-
ated by three blinded observers and classified into four
stages where stage 0 = no arterial dilation or irregular
shapes, stage 1 = slight protrusion (diameter of the
aneurysmal protrusion < half of the diameter of the parent
artery), stage 2 = moderate protrusion (half the diameter
of the parent artery < diameter of the protrusion < diam-
eter of the parent artery), and stage 3 = a well-developed
saccular aneurysm (diameter of the aneurysm > diameter
of the parent artery).
RNA isolation and qRT-PCR assay
The mRNA levels in the vascular wall from sham, con-
trol, and MET rats (n = 6 in each group) were deter-
mined by qRT-PCR assay. The mRNA levels in another
set of MET- and MET + FA rats (n = 6 in each group)
were also compared. The rats were euthanized 12 weeks
after aneurysm induction. The AcomA and the left
ACA-OA bifurcation were isolated and total RNA was
extracted with the EZ1 RNA Universal Tissue Kit
(QIAGEN, Tokyo, Japan) and placed in a MagNA lyser
(Roche, Tokyo, Japan). For reverse transcription of total
RNA to cDNA, we used the transcriptor first-strand
cDNA synthesis kit (Roche). qRT-PCR assay of each sam-
ple was in a LightCycler 2.0 instrument (Roche Diagnos-
tics, Tokyo, Japan). LightCycler FastStart DNA master and
SYBR green I (Roche) were used for MMP-9, tissue inhibi-
tor of metalloproteinase (TIMP)1, TIMP2, NOX4, Rac1,
angiotensin-converting enzyme (ACE), tumor necrosis fac-
tor (TNF)α, interleukin (IL)-6, and glyceraldehyde-3 phos-
phate dehydrogenase (GAPDH) assays. The primers were
For rat MMP-9: forward primer (F), 5′-ACA ACG TCT
TTC ACTACC AA-3′, reverse primer (R), 5′-CAA
AAG AGG AGC CTTAGT TC-3′
for TIMP1: F, 5′-TCC TGG TTC CCT GGC ATA AT-
3′, R, 5′-GGC AAA GTG ATC GCT CTG GT-3′
for TIMP2: F, 5′-CCC TCT GTG ACT TTATTG TGC-
3′, R, 5′-TGATGC TCT TCT CTG TGA CC-3′
for NOX4: F, 5′-AGA CAT CCA ATC ATT CCA
GTG GTT TGC AGA C-3′, R, 5′-TGC TCT ATG
TGC TGC ATA ACA AGT TTT GGC AA-3′
for Rac1: F, 5′-CTG TCT TGA GTC CTC GCT
GTG TGA GTG CTG-3′, R, 5′-CAG CAG GCA
TTT TCT CTT CC-3′
for TNFα, F, 5′-CCC AAC AAG GAG GAG AAG T-
3′, R, 5′-CGC TTG GTG GTT TGC TAC-3′
for IL-6, F, 5′-TCT CAG GGA GAT CTT GGA AAT G-
3′, R, 5′-TAG AAA CGG AAC TCC AGA AGA C-3′
for GAPDH, F, 5′-TAC ACT GAG GAC CAG GTT
G-3′, R, 5′-CCC TGT TGC TGT AGC CAT A-3′.
Primers and probe sets for ACE were from Roche and
used according to the manufacturer’s directions. The
amplified product was separated on 1.5 % agarose gels
containing EtBr solution (Wako, Osaka, Japan) and visu-
alized on an ultraviolet transilluminator. The results
were quantified after normalization to the expression of
GAPDH mRNA. The PCR conditions were 95 °C for
10 min followed by 40 cycles at 95 °C for 10 s, 60 °C for
10 s, and 72 °C for 8 s. We subjected samples from each
group to two independent qRT-PCR assays. GAPDH
was the internal control.
Immunofluorescent studies
In a separate set of experiments, 3 MET and 3 control rats
were prepared for immunofluorescence studies. After per-
fusion with 4 % paraformaldehyde, we inspected the ves-
sels in the circle of Willis under a dissecting microscope.
The AcomA was carefully dissected and immersed in 4 %
paraformaldehyde. The arteries were rinsed with PBS,
embedded in OCT compound (Tissue-Tek, Inc.), and 6-
μm-thick serial sections were cut with a cryotome (CM
1850; Leica). After 30-min serum-free protein blockade
(Dako, Carpinteria, CA, USA), primary antibodies diluted
with Canget signal immunostain (Toyobo, Osaka, Japan)
were added for 1-h incubation at room temperature (RT)
or overnight at 4 °C. Primary antibodies against MMP-9,
CD163 (Abcam, CA, USA), CD11b (BioLegend, CA, USA),
and CD68 (Abbiotec, CA, USA) were applied. Sections
were then incubated for 1 h at RT with the fluorescein-
conjugated secondary antibodies Alexa Fluor 488 or 594
(Molecular Probes, CA, USA) in Canget signal immuno-
stain, mounted with Vectashield (Vector Laboratories, CA,
USA), and examined under a fluorescence microscope
(Olympus IX71, Tokyo, Japan).
Statistical analysis
Sequentially obtained data (mean ± SD) were analyzed
with Student’s t test for 2-group comparisons and ana-
lysis of variance (ANOVA) followed by Scheffe’s test for
multiple comparisons. The incidence of ruptured aneu-
rysms and of cerebral aneurysmal changes was analyzed
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with Fisher’s exact probability test. Statistical analyses were
performed with statistical software (StatView 5). Differ-
ences were considered statistically significant at p < 0.05.
Results
Excessive MET intake promotes the rupture of rat
cerebral aneurysms
MET forms Hcy via numerous adenosylmethionine-
dependent methyl transfer reactions. The plasma Hcy
level was significantly higher in MET-than control rats
(p < 0.01, Fig. 1a), confirming HHcy in the MET rats.
The average MET intake in the course of 12 weeks was
772 ± 118 mg/kg/day. In MET-and control rats, we ob-
served hypertension at 4 weeks after aneurysm induction
(Additional file 1: Figure S1A). The blood pressure and
body weight were not affected by MET (Additional file 1:
Figure S1A, S1B). During the 12-week post-induction ob-
servation period, the incidence of aneurysmal rupture was
significantly higher at 6 and 8 weeks; the total incidence
tended to be higher in MET than control rats at 10 and
12 weeks (Fig. 1b). Aneurysmal rupture sites were observed
at the AcomA and the PW (Fig. 1c, d). We observed no
ruptures at the ACA-OA bifurcation. These results
suggest that excessive MET intake promoted aneurysmal
rupture at the AcomA and PW.
Excessive MET intake may increase the vulnerability of
the AcomA wall
Since the incidence of rupture was almost equal at the
AcomA and the PW, we examined the morphology at the
AcomA to identify factors that render the vessel wall
prone to rupture. We classified the aneurysmal changes
observed on corrosion cast into four stages (Fig. 2a). There
were significantly more stage 2 and 3 changes and more
ruptured aneurysms in the MET-than the control rats
(Fig. 2b), suggesting that excessive MET intake promotes
the growth and rupture of AcomA aneurysms. There was
no significant difference in the rate of aneurysm formation
at the ACA-OA bifurcation between control-and MET
rats (Additional file 2: Figure S2A). HHcy induced by over-
dosing with MET may exacerbate the site-specific vulner-
ability of the vessel wall and aneurysmal instability.
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Fig. 1 Excessive methionine (MET) intake increased the incidence of cerebral aneurysmal rupture. a The plasma homocysteine (Hcy) level in MET-
treated rats was significantly higher than in the controls. Plasma Hcy was measured by radioimmunoassay (each group, n = 5). *p < 0.01 vs control
rats by Student’s t test (mean ± SD). b The total rupture rate was significantly higher in MET-treated rats (n = 25) than in the controls (n = 19) at 6
and 8 weeks after aneurysm induction. *p < 0.05 vs control rats by Fisher’s exact probability test. c Representative photographs of subarachnoid
hemorrhage (SAH) due to the rupture of aneurysms at the anterior communicating artery (AcomA) (left) and the posterior half of the circle of
Willis (PW) (right). Aneurysm formations were found after the removal of the blood clot from SAH (lower photographs). The location of aneurysms
is indicated by rectangles. White arrows indicate aneurysms. Bars = 2.5 mm. d The incidence of rupture of AcomA and PW aneurysms in MET-treated
and control rats
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Excessive MET intake is associated with increased M1
macrophage infiltration into the AcomA wall and with
vascular degradation
Immunohistochemically, CD68-positive cells are periph-
eral macrophages and CD11b and CD163 are expressed
in differentiated M1 and M2 macrophages, respectively.
M1 and M2 macrophages are associated with pro-
inflammatory- and anti-inflammatory responses, re-
spectively. CD68- and CD11b- but not CD163-positive
cells were increased in MET rats and they were co-
localized (Fig. 3a, b, d). MMP-9-positive cells were also
increased in MET-(Fig. 3a) but not in control rats. They
co-localized with CD11b-positive cells (Fig. 3c).
The mRNA level of MMP-9, the ratio of MMP-9 to
TIMP2, and the IL-6 level were significantly higher in
MET-than control rats (Fig. 4a, b, d). The MMP-9 to
TIMP1 ratio at the AcomA (Fig. 4c) and the ratio of
MMP-9 to TIMP2 at the ACA-OA bifurcation (Additional
file 2: Figure S2B) were not significantly different in MET
and control rats. The increase in MMP-9, the disequilib-
rium in the MMP-9 to TIMP2 ratio, and the infiltration of
M1 macrophages may be associated with the vulnerability
of the AcomA wall.
The mRNA level of NOX4 (Fig. 5a), ACE (Fig. 5c),
and TNFα (Fig. 5d) was higher in the AcomA wall of
control-and MET than of sham rats. There was no sig-
nificant difference between control and MET rats. The
mRNA level of Rac1 (Fig. 5b) in control- and MET rats
was similar to the sham rats. These observations suggest
that the vascular wall in both groups was exposed to a
similar degree of oxidative stress and RAS activation and
that these factors may not be directly associated with
aneurysmal growth or rupture.
The inhibition of conversion from MET to Hcy attenuates
the development of AcomA aneurysms by inhibiting
vascular degradation
Hcy is degraded by FA. We treated MET rats with FA
(MET + FA) to confirm the relationship between HHcy
and aneurysms at the AcomA. As expected, their plasma
Hcy level was normalized by FA (Additional file 3:
Figure S3A); it did not affect the systolic blood pressure
(Additional file 3: Figure S3B). The rupture rate was sig-
nificantly lower in MET + FA-than MET-only rats
12 weeks after aneurysm induction (Fig. 6a) and the inci-
dence of stage 2 and 3 morphologic changes and of
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ruptured AcomA aneurysms was significantly lower in
MET + FA than MET-only rats (Fig. 6b). The increase in
the expression of MMP-9 and in the ratio of MMP-9 to
TIMP2 at the AcomA seen in the presence of HHcy was
abolished (Fig. 6c, d). These results suggest that the deg-
radation of the AcomA wall is attributable to HHcy.
Discussion
In this study, we first demonstrate that HHcy induced by
excessive MET intake promotes the growth of AcomA-
and the rupture of AcomA and PW aneurysms. In MET
rats, we observed an increase in the infiltration of M1
macrophages, the expression of MMP-9, and the ratio of
MMP-9 to TIMP2 at the AcomA. Treatment with FA re-
duced HHcy, attenuated the effects of MET, and pre-
vented the growth and rupture of aneurysms. Our
findings suggest that the vulnerability of the AcomA wall
in MET rats is at least partly attributable to HHcy and
that its suppression may help to prevent the growth and/
or rupture of cerebral aneurysms.
Up to 40 % of patients diagnosed with premature coron-
ary artery disease, peripheral vascular disease, or recurrent
venous thrombosis manifested HHcy [21, 22]. However, it
is unclear whether HHcy is a causative factor or a result of
these diseases. In mice, the oral administration of FA or of
a combination of B vitamins decreased HHcy and attenu-
ated atherogenesis [23]. These observations support our
present findings that HHcy promotes the growth and
rupture of cerebral aneurysms.
In humans, efforts to lower HHcy by therapy with FA
and vitamin B did not reduce the incidence of cardiovas-
cular events [22, 24]. The daily combined intake of FA
and vitamins B6 and B12 for 5 years failed to signifi-
cantly reduce the rate of major vascular events in a
high-risk population with vascular disease, possibly be-
cause it failed to reverse epigenetic changes induced by
A
a c d
b e f
a
b
a
a b c
b c
B C
D
Fig. 3 Evaluation of pathological changes at the AcomA wall by Elastica van Gieson and immunofluorescence staining. a EVG (a, b) and
immunofluorescence staining for CD68 (c, red) and MMP-9 (d, green) in control rats and for CD68 (e, red) and MMP-9 (f, green) in methionine
(MET)-treated rats. b Immunofluorescence staining for CD11b (a, red), CD163 (b, green) in MET-treated rats. c Immunofluorescence staining for
CD11b (a, green), MMP-9 (b, red), and merged stains (c) in MET-treated rats. d Immunofluorescence staining for CD11b (a, green), CD68 (b, red),
and merged stains (c) in MET-treated rats
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HHcy [24]. Saposnik et al. [25] found that while FA
helped to lower Hcy and vitamins B6 and B12 reduced
the overall risk for stroke, there was no effect on stroke
severity and post-stroke disability. On the other hand,
among adult hypertensive Chinese with no history of
stroke or myocardial infarction, the combined use of
enalapril, an angiotensin-converting enzyme inhibitor,
and FA significantly reduced the risk for a first stroke,
compared to patients treated with enalapril alone [26].
Epigenetic factors may contribute differently to cardiovas-
cular and cerebrovascular diseases. Combination therapies
aimed at improving the epigenetic machinery and lower-
ing circulating Hcy levels may be more beneficial. Since
the blood pressure in our MET + FA rats was not affected,
we posit that HHcy contributed to the growth and
rupture of their cerebral aneurysms in a blood pressure-
independent manner.
Many macrophages were observed in the human lu-
minal and abluminal layer of large unruptured and rup-
tured aneurysms [27, 28]. Elsewhere, we demonstrated
that in our rat aneurysm model, the degradation of
endothelial tight junctions facilitated macrophage infiltra-
tion into the vascular wall [29]. While pro-inflammatory
M1 and anti-inflammatory M2 macrophages were present
in equal proportion in unruptured aneurysms, the number
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of M1 macrophages was increased in ruptured aneurysms
[30]. Yao et al. reported that IL-6 increased MMP-9 activ-
ity in human cerebral smooth muscle cells in vitro [31].
Tissue-infiltrating macrophages not only release pro-
inflammatory cytokines that lead to the recruitment of
additional inflammatory cells, but they also release MMPs
that digest the extracellular matrix of the arterial wall,
resulting in further damage via the up-regulation of other
proteinases. Thus, the infiltration of macrophages and
macrophage-derived MMPs may be closely associated
with aneurysmal growth. The increase in CD68+/CD11b+
macrophages and the elevated mRNA level of IL-6 in the
AcomA wall of MET rats may reflect this phenomenon.
On the other hand, others [32, 33] reported that the
highest wall shear stress involved the AcomA rather
than other cerebral arterial bifurcations and that it was
highly oscillatory. Oscillatory wall shear stress increased
the expression of MMP-9 in endothelial cells [34] and
Sho et al. [35] reported that high flow and shear stress
can induce endothelial and smooth muscle cells to ex-
press MMP-2 and MMP-9; they also documented a dis-
proportional increase in TIMP2. As we did not directly
assess the blood flow, we cannot comment on the rela-
tionship between hemodynamics and the propensity of
AcomA aneurysms to rupture. Whether the imbalance
between MMP-9 and TIMP2 at the AcomA is associated
with complex hemodynamics remains to be determined.
The expression of macrophage-derived MMP-9 is critical
for vascular wall remodeling. It was significantly increased
in the wall of cerebral aneurysms in rats exposed to HHcy
[7] and the selective inhibition of MMP blocked aneu-
rysmal progression [36]. Therapies targeting MMP-9 and
TIMP2 may be promising candidates in efforts to prevent
the growth and rupture of cerebral aneurysms.
Elsewhere [11–15], we reported that RAS, oxidative
stress, and inflammation were strongly associated with the
formation of cerebral aneurysms. In the current study, the
expression of these molecules was higher in both our
MET and control rats than in the sham rats. However,
there was no significant difference between MET and con-
trol rats although the MET rats harbored a significantly
higher grade of AcomA aneurysms than the controls, sug-
gesting that these molecules may be associated with the
formation of cerebral aneurysms but that they may not be
directly associated with aneurysmal growth or rupture.
Our study has some limitations. As it was difficult to
obtain samples just after rupture, we could not assess
differences in the molecule levels between ruptured and
unruptured AcomA aneurysms. We also did not deter-
mine whether the AcomA used for the analysis of the
mRNA level harbored aneurysms. Although we docu-
ment the relationship between the increase in degrad-
ation molecules and AcomA aneurysms with an unstable
wall, we were unable to identify the detailed mechanisms
underlying aneurysmal rupture. Since we excluded rats
with ruptured aneurysms at the PW, there is sampling
bias in assessment of aneurysmal changes at AcomA
(Figs. 2b and 6b).
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Fig. 6 Folic acid (FA) attenuated the development of cerebral aneurysms. a Methionine (MET)-only (n = 32) and MET + FA-treated rats (n = 17). FA
lowered the total rupture rate observed at 12 weeks after aneurysmal induction. *p < 0.05 vs MET-only rats by Fisher’s exact probability test. b The
total rates of stage 2 and stage 3 aneurysmal wall changes and of rupture were significantly lower in MET + FA than in MET-only rats (18 vs 58 %,
*p < 0.01 vs MET-only rats by Fisher’s exact probability test). c, d FA decreased the expression of MMP-9 and of the MMP-9 to TIMP2 ratio.
*p < 0.05 vs MET-only rats by Student’s t test
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Conclusions
We provide new evidence that HHcy elicited by an ex-
cessive MET intake is associated with the vulnerability
of the vascular wall at the AcomA. Suppressing inflam-
mation, vascular degradation, and macrophage infiltra-
tion may prevent aneurysmal rupture. Our findings may
pave the way for the development of pharmacological
therapies to address human cerebral aneurysms.
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